Clinical studies have revealed that mutations in METTL5, the methyltransferase responsible for 18S rRNA m6A modification, can result in intellectual disability, microcephaly, and craniofacial anomalies (Lei et al., 2023). This evidence concerns the gene METTL5 and microcephaly.